Kcs Wealth Advisory Pfizer Inc Transaction History

Kcs Wealth Advisory

$224 Million
Q3 2023

A detailed history of Kcs Wealth Advisory transactions in Pfizer Inc stock. As of the latest transaction made, Kcs Wealth Advisory holds 22,900 shares of PFE stock, worth $599,751. This represents 0.34% of its overall portfolio holdings.

Number of Shares

22,900

Previous 12,431 84.22%

Holding current value

$599,751

Previous $455,000 66.81%

% of portfolio

0.34%

Previous 0.17%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$32.09 - $37.51 $335,950 - $392,692	10,469 Added 84.22%	22,900 $759,000
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $9,102 - $10,531	-252 Reduced 1.99%	12,431 $455,000
Q1 2023 Apr 17, 2023	SELL	$39.39 - $51.28 $158,899 - $206,863	-4,034 Reduced 24.13%	12,683 $517,000
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $181,236 - $236,584	4,341 Added 35.08%	16,717 $856,000
Q3 2022 Oct 21, 2022	SELL	$43.76 - $53.42 $4,551 - $5,555	-104 Reduced 0.83%	12,376 $542,000
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $25,591 - $30,343	-550 Reduced 4.22%	12,480 $654,000
Q1 2022 Apr 13, 2022	SELL	$45.75 - $56.69 $23,652 - $29,308	-517 Reduced 3.82%	13,030 $675,000
Q4 2021 Jan 26, 2022	BUY	$41.32 - $61.25 $35,617 - $52,797	862 Added 6.8%	13,547 $800,000
Q3 2021 Oct 20, 2021	SELL	$39.25 - $50.42 $3,846 - $4,941	-98 Reduced 0.77%	12,685 $546,000
Q2 2021 Jul 27, 2021	BUY	$35.91 - $40.68 $17,955 - $20,340	500 Added 4.07%	12,783 $501,000
Q1 2021 Apr 19, 2021	SELL	$33.49 - $37.77 $1,741 - $1,964	-52 Reduced 0.42%	12,283 $445,000
Q4 2020 Jan 28, 2021	BUY	$33.47 - $42.56 $412,852 - $524,977	12,335 New	12,335 $454,000
Q4 2019 Jan 15, 2020	SELL	$32.92 - $37.36 $117,623 - $133,487	-3,573 Closed	0 $0
Q3 2019 Oct 29, 2019	BUY	$32.49 - $42.13 $116,086 - $150,530	3,573 New	3,573 $121,000

Others Institutions Holding PFE

# of Institutions

3,267

Shares Held

3.73B

Call Options Held

74.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcs Wealth Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Kcs Wealth Advisory with notifications on news.

Account

Kcs Wealth Advisory Pfizer Inc Transaction History